B69.81 Myositis in cysticercosis

Name of the Condition

• Myositis in cysticercosis

Summary

Myositis in cysticercosis is a parasitic infection involving inflammation of muscle tissue caused by the larval stage of the pork tapeworm, Taenia solium. The condition occurs when ingested tapeworm eggs develop into cysts (larvae) within muscle fibers, leading to localized inflammation. It is a manifestation of cysticercosis that can present with muscle-related symptoms depending on cyst burden and location.

Causes

The infection is caused by the larval form of Taenia solium, which is acquired by ingesting eggs from contaminated food, water, or surfaces. The eggs hatch in the intestine, and larvae penetrate the intestinal wall to migrate to tissues, where they form cysts. Human-to-human transmission occurs via the fecal-oral route, often through poor sanitation or consumption of undercooked pork.

Risk Factors

• Residence in or travel to areas with poor sanitation and high Taenia solium prevalence.
• Consumption of undercooked pork or contaminated food/water.
• Close contact with individuals carrying the adult tapeworm (e.g., household members).
• Immunocompromised states that may alter disease progression.

Symptoms

• Muscle pain, tenderness, or swelling at the cyst site.
• Limited range of motion or functional impairment due to muscle inflammation.
• Palpable muscle nodules or cysts.
• Asymptomatic cases may occur with incidental imaging findings.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., MRI or ultrasound of affected muscles), and serological tests for Taenia solium antibodies. Muscle biopsy may be performed to confirm cysticercal larvae in tissue. Imaging typically shows cystic lesions within muscle fibers, and serology helps assess exposure or active infection.

Treatment Options

Treatment may include antiparasitic medications (e.g., albendazole or praziquantel) to target the cysts, along with anti-inflammatory drugs to manage myositis symptoms. In some cases, surgical removal of cysts is considered if they cause significant pain or functional impairment. Symptomatic care, such as pain management, is also provided as needed.

Prognosis and Follow-Up

Prognosis is generally favorable with appropriate treatment, though outcomes depend on cyst burden, location, and response to therapy. Follow-up may include monitoring for symptom resolution, repeat imaging to assess cyst viability, and serological testing to confirm eradication. Long-term follow-up is recommended to detect potential complications or recurrence.

Complications

• Persistent muscle inflammation or fibrosis.
• Secondary bacterial infection of cysts.
• Functional impairment if cysts affect critical muscle groups.
• Rarely, dissemination to other tissues if left untreated.

Lifestyle & Prevention

• Practice good hygiene, including handwashing and safe food handling.
• Avoid consumption of undercooked pork or contaminated water.
• Improve sanitation in endemic areas to reduce fecal-oral transmission.
• Seek prompt medical evaluation for suspected exposure or symptoms.

When to Seek Professional Help

Consult a healthcare provider if you experience unexplained muscle pain, swelling, or nodules, especially after travel to endemic regions or exposure to contaminated sources. Seek immediate care for severe pain, functional impairment, or signs of infection.

Tips for Medical Coders

Document the presence of muscle inflammation (myositis) and its association with cysticercosis to support the B69.81 code. Include details on diagnostic methods (e.g., imaging, biopsy) and treatment to clarify the clinical context. Ensure documentation links muscle symptoms to cysticercosis rather than other causes to justify the specific code.